🇺🇸 FDA
Patent

US 10144762

Antibacterial antisense oligonucleotide and method

granted A61KA61K48/00A61P

Quick answer

US patent 10144762 (Antibacterial antisense oligonucleotide and method) held by Sarepta Therapeutics, Inc. expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K48/00, A61P, A61P31/04